Citation Impact
Citing Papers
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
2007 StandoutScienceNobel
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
SA-4-1BBL and Monophosphoryl Lipid A Constitute an Efficacious Combination Adjuvant for Cancer Vaccines
2014
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens
2001
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Viral vectors for dendritic cell-based immunotherapy
2001
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
IFN- mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome
2003
Cut and trim: generating MHC class I peptide ligands
2001
Features of the dendritic cell lineage
2010 StandoutNobel
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Spermidine/Spermine-N1-Acetyltransferase 2 Is an Essential Component of the Ubiquitin Ligase Complex That Regulates Hypoxia-inducible Factor 1α
2007 StandoutNobel
Adjuvants for cancer vaccines
2010
Vaccines Against Drug Abuse
2011
Imaging in the era of molecular oncology
2008 StandoutNature
Calcineurin Promotes Hypoxia-inducible Factor 1α Expression by Dephosphorylating RACK1 and Blocking RACK1 Dimerization
2007 StandoutNobel
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells
2013
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
A listing of human tumor antigens recognized by T cells
2001
The cell biology of antigen presentation in dendritic cells
2001
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
Towards patient‐specific tumor antigen selection for vaccination
2002
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
2014
Dual biological effects of the cytokines interleukin-10 and interferon-γ
2011
New adjuvants for human vaccines
2010
A listing of human tumor antigens recognized by T cells: March 2004 update
2004
Sources of diversity in T cell epitope discovery
2011
Tumor‐specific shared antigenic peptides recognized by human T cells
2002
Antigen processing by the proteasome
2001
Four-and-a-Half LIM Domain Proteins Inhibit Transactivation by Hypoxia-inducible Factor 1
2012 StandoutNobel
OS-9 Interacts with Hypoxia-Inducible Factor 1α and Prolyl Hydroxylases to Promote Oxygen-Dependent Degradation of HIF-1α
2005 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Antigen Processing and Remodeling of the Endosomal Pathway: Requirements for Antigen Cross-Presentation
2012
Control of cross‐presentation during dendritic cell maturation
2004
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Antigens for cancer immunotherapy
2008
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
The function of the proteasome system in MHC class I antigen processing
2000
Identification of human tumor antigens and its implications for diagnosis and treatment of cancer
2004
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1α (HIF-1α) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1α
2007 StandoutNobel
Mechanism-Based Profiling of Enzyme Families
2006
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
2001 StandoutNobel
HLA-Binding Properties of Tumor Neoepitopes in Humans
2014
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
2003
Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH)
2006 StandoutNobel
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
2002 StandoutNobel
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination
2004 StandoutNobel
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
HUMAN T CELL RESPONSES AGAINST MELANOMA
2005
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Neoantigens in cancer immunotherapy
2015 StandoutScience
Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells.
2002
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Arylfluorosulfates Inactivate Intracellular Lipid Binding Protein(s) through Chemoselective SuFEx Reaction with a Binding Site Tyr Residue
2016 StandoutNobel
Antigen Presentation and T Cell Stimulation by Dendritic Cells
2002
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells
2011
Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver
2001
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO
2005
Works of Sandra Morel being referenced
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome
2004 Science
Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome
2001
Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
2011
Processing of Some Antigens by the Standard Proteasome but Not by the Immunoproteasome Results in Poor Presentation by Dendritic Cells
2000
Two new tumor‐specific antigenic peptides encoded by gene MAGE‐C2 and presented to cytolytic T lymphocytes by HLA‐A2
2004
Production of an antigenic peptide by insulin-degrading enzyme
2010
The Production of a New MAGE-3 Peptide Presented to Cytolytic T Lymphocytes by HLA-B40 Requires the Immunoproteasome
2002
Identification of a new peptide recognized by autologous cytolytic T lymphocytes on a human melanoma.
2002
The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases
2002
Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells ControlsIn vivoT-Cell Responses
2006
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
2009
Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation
2006
Enhancement of Adaptive Immunity by the Human Vaccine Adjuvant AS01 Depends on Activated Dendritic Cells
2014